The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019

被引:460
作者
Khanh Bao Tran [1 ,2 ]
Lang, Justin J. [3 ]
Compton, Kelly [4 ]
Xu, Rixing [4 ]
Acheson, Alistair R. [4 ]
Henrikson, Hannah Jacqueline [4 ,12 ]
Kocarnik, Jonathan M. [4 ]
Penberthy, Louise [4 ]
Aali, Amirali [13 ,23 ]
Abbas, Qamar [31 ]
Abbasi, Behzad [32 ,63 ]
Abbasi-Kangevari, Mohsen [64 ]
Abbasi-Kangevari, Zeinab [33 ,64 ]
Abbastabar, Hedayat [34 ]
Abdelmasseh, Michael [81 ]
Abd-Elsalam, Sherief [82 ]
Abdelwahab, Ahmed Abdelwahab [83 ]
Abdoli, Gholamreza [84 ]
Abdulkadir, Hanan Abdulkadir [89 ]
Abedi, Aidin [100 ,101 ]
Abegaz, Kedir Hussein [103 ,104 ]
Abidi, Hassan [106 ]
Aboagye, Richard Gyan [108 ]
Abolhassani, Hassan [35 ,111 ]
Absalan, Abdorrahim [112 ,114 ]
Abtew, Yonas Derso [90 ]
Ali, Hiwa Abubaker [115 ]
Abu-Gharbieh, Eman [118 ]
Achappa, Basavaprabhu [124 ]
Acuna, Juan Manuel [129 ,130 ]
Addison, Daniel [132 ]
Addo, Isaac Yeboah [133 ,136 ]
Adegboye, Oyelola A. [137 ]
Adesina, Miracle Ayomikun [138 ,139 ]
Adnan, Mohammad [146 ]
Adnani, Qorinah Estiningtyas Sakilah [147 ]
Advani, Shailesh M. [148 ,149 ]
Afrin, Sumia [151 ]
Afzal, Muhammad Sohail [153 ]
Aggarwal, Manik [155 ]
Ahinkorah, Bright Opoku [158 ]
Ahmad, Araz Ramazan [159 ,160 ]
Ahmad, Rizwan [162 ]
Ahmad, Sohail [167 ,168 ]
Ahmadi, Sepideh [65 ]
Ahmed, Haroon [169 ]
Ahmed, Luai A. [170 ]
Ahmed, Muktar Beshir [174 ,178 ]
Rashid, Tarik Ahmed [179 ]
Aiman, Wajeeha [180 ]
机构
[1] Univ Auckland, Dept Mol Med & Pathol, Auckland, New Zealand
[2] Maurice Wilkins Ctr, Dept Clin Hematol AndToxicol, Auckland, New Zealand
[3] Publ Hlth Agcy Canada, Ctr Surveillance & Appl Res, Ottawa, ON, Canada
[4] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA
[5] Univ Washington, Sch Med, Dept Hlth Metr Sci, Seattle, WA USA
[6] Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA
[7] Univ Washington, Div Plast & Reconstruct Surg, Seattle, WA 98195 USA
[8] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA
[9] Univ Washington, Div Pediat Hematol Oncol, Seattle, WA 98195 USA
[10] Boston Univ, Hlth Informat Lab, Boston, MA 02215 USA
[11] Boston Univ, Dept Comp Sci, 111 Cummington St, Boston, MA 02215 USA
[12] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA
[13] Mashhad Univ Med Sci, Fac Med, Mashhad, Razavi Khorasan, Iran
[14] Mashhad Univ Med Sci, Educ Dev Ctr, Mashhad, Razavi Khorasan, Iran
[15] Mashhad Univ Med Sci, Learning Ctr, Mashhad, Razavi Khorasan, Iran
[16] Mashhad Univ Med Sci, Sch Med, Mashhad, Razavi Khorasan, Iran
[17] Mashhad Univ Med Sci, Dept Nursing, Mashhad, Razavi Khorasan, Iran
[18] Mashhad Univ Med Sci, Appl Biomed Res Ctr, Mashhad, Razavi Khorasan, Iran
[19] Mashhad Univ Med Sci, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran
[20] Mashhad Univ Med Sci, Dept Med Informat, Mashhad, Razavi Khorasan, Iran
[21] Mashhad Univ Med Sci, Clin Res Dev Unit, Mashhad, Razavi Khorasan, Iran
[22] Mashhad Univ Med Sci, Mashhad, Razavi Khorasan, Iran
[23] Shiraz Univ Med Sci, Hlth Policy Res Ctr, Shiraz, Iran
[24] Shiraz Univ Med Sci, Hlth Informat Management, Shiraz, Iran
[25] Shiraz Univ Med Sci, Dept Epidemiol, Shiraz, Iran
[26] Shiraz Univ Med Sci, Res Ctr Hlth Sci, Shiraz, Iran
[27] Shiraz Univ Med Sci, Dept Environm Hlth, Shiraz, Iran
[28] Shiraz Univ Med Sci, Dept Radiol, Shiraz, Iran
[29] Shiraz Univ Med Sci, Noncommunicable Dis Res Ctr, Shiraz, Iran
[30] Shiraz Univ Med Sci, Dept Med Mycol & Parasitol, Shiraz, Iran
[31] Univ Bahrain, Dept Biol, Manama, Bahrain
[32] Univ Tehran Med Sci, Uro Oncol Res Ctr, Tehran, Iran
[33] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Tehran, Iran
[34] Univ Tehran Med Sci, Adv Diagnost & Intervent Radiol Res Ctr, Tehran, Iran
[35] Univ Tehran Med Sci, Res Ctr Immunodeficiencies, Tehran, Iran
[36] Univ Tehran Med Sci, Dept Epidemiol & Biostat, Tehran, Iran
[37] Univ Tehran Med Sci, Universal Sci Educ & Res Network, Tehran, Iran
[38] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran
[39] Univ Tehran Med Sci, Expt Med Res Ctr, Tehran, Iran
[40] Univ Tehran Med Sci, Dept Hlth Policy Management & Econ, Tehran, Iran
[41] Univ Tehran Med Sci, Natl Inst Hlth Res, Tehran, Iran
[42] Univ Tehran Med Sci, Multiple Sclerosis Res Ctr, Tehran, Iran
[43] Univ Tehran Med Sci, Dept Pathol, Tehran, Iran
[44] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[45] Univ Tehran Med Sci, Endocrinol & Metab Res Inst, Tehran, Iran
[46] Univ Tehran Med Sci, Dept Surg, Tehran, Iran
[47] Univ Tehran Med Sci, Ophthalmol Dept, Tehran, Iran
[48] Univ Tehran Med Sci, Digest Oncol Res Ctr, Tehran, Iran
[49] Univ Tehran Med Sci, Students Sci Res Ctr, Tehran, Iran
[50] Univ Tehran Med Sci, Childrens Med Ctr, Tehran, Iran
关键词
SOCIAL DETERMINANTS; MODIFIABLE FACTORS; LIFE-STYLE; COVID-19; HEALTH; OBESITY; DEATHS; IMPACT; UK;
D O I
10.1016/S0140-6736(22)01438-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4.45 million (95% uncertainty interval 4.01-4.94) deaths and 105 million (95.0-116) DALYs for both sexes combined, representing 44.4% (41.3-48.4) of all cancer deaths and 42.0% (39.1-45.6) of all DALYs. There were 2.88 million (2.60-3.18) risk-attributable cancer deaths in males (50.6% [47.8-54.1] of all male cancer deaths) and 1.58 million (1.36-1.84) risk-attributable cancer deaths in females (36.3% [32.5-41.3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20.4% (12.6-28.4) and DALYs by 16.8% (8.8-25.0), with the greatest percentage increase in metabolic risks (34.7% [27.9-42.8] and 33.3% [25.8-42.0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
引用
收藏
页码:563 / 591
页数:29
相关论文
共 46 条
  • [1] [Anonymous], 1992, IARC Monogr Eval Carcinog Risks Hum, V55, P1
  • [2] [Anonymous], 2007, Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective
  • [3] [Anonymous], 2005, INT STAT CLASS DIS R, V2
  • [4] [Anonymous], 2017, Tackling NCDs: best buys and other recommended interventions for the prevention and control of noncommunicable diseases
  • [5] Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012
    Arnold, Melina
    de Vries, Esther
    Whiteman, David C.
    Jemal, Ahmedin
    Bray, Freddie
    Parkin, Donald Maxwell
    Soerjomataram, Isabelle
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (06) : 1305 - 1314
  • [6] Global burden of cancer attributable to high body-mass index in 2012: a population-based study
    Arnold, Melina
    Pandeya, Nirmala
    Byrnes, Graham
    Renehan, Andrew G.
    Stevens, Gretchen A.
    Ezzati, Majid
    Ferlay, Jacques
    Miranda, J. Jaime
    Romieu, Isabelle
    Dikshit, Rajesh
    Forman, David
    Soerjomataram, Isabelle
    [J]. LANCET ONCOLOGY, 2015, 16 (01) : 36 - 46
  • [7] The burden of cancer attributable to modifiable risk factors: the Australian cancer-PAF cohort consortium
    Arriaga, Maria E.
    Vajdic, Claire M.
    Canfell, Karen
    MacInnis, Robert
    Hull, Peter
    Magliano, Dianna J.
    Banks, Emily
    Giles, Graham G.
    Cumming, Robert G.
    Byles, Julie E.
    Taylor, Anne W.
    Shaw, Jonathan E.
    Price, Kay
    Hirani, Vasant
    Mitchell, Paul
    Adelstein, Barbara-Ann
    Laaksonen, Maarit A.
    [J]. BMJ OPEN, 2017, 7 (06):
  • [8] Overweight, obesity, and cancer risk
    Bianchini, F
    Kaaks, R
    Vainio, H
    [J]. LANCET ONCOLOGY, 2002, 3 (09) : 565 - 574
  • [9] The causes of cancer in France
    Boffetta, P.
    Tubiana, M.
    Hill, C.
    Boniol, M.
    Aurengo, A.
    Masse, R.
    Valleron, A. -J.
    Monier, R.
    de The, G.
    Boyle, P.
    Autier, P.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (03) : 550 - 555
  • [10] The Social Determinants of Health: It's Time to Consider the Causes of the Causes
    Braveman, Paula
    Gottlieb, Laura
    [J]. PUBLIC HEALTH REPORTS, 2014, 129 : 19 - 31